Regen BioPharma, Inc.
RGBP
$0.026
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.84% | -34.44% | -65.50% | -157.28% | -151.48% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 143.17% | 373.96% | 601.89% | 3,122.22% | 215.91% |
| Total Other Non-Cash Items | 150.24% | -36.04% | -36.04% | -74.10% | -35.97% |
| Change in Net Operating Assets | 36.02% | 570.60% | 453.60% | 88.88% | 94.52% |
| Cash from Operations | 34.37% | -1.47% | -83.36% | -298.56% | -140.71% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 69.54% | 30.60% | -65.18% | -92.17% | 43.08% |
| Total Debt Repaid | 180.20% | 186.01% | 178.49% | -- | -- |
| Issuance of Common Stock | -94.75% | -59.17% | 65.47% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -50.30% | -12.63% | 15.43% | 134.95% | 525.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -198.36% | -695.83% | -248.45% | -272.35% | 155.39% |